×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Cognition Therapeutics Inc. (CGTX) NASDAQ

$1.95 (0.03) (-1.52%)

Market Cap: $79.32M

As of 05/15/24 04:00 PM EDT. Market closed.

(CGTX)

Cognition Therapeutics Inc. (CGTX)
NASDAQ

$1.95
(0.03) (-1.52%)

Market Cap: $79.32M

As of 05/15/24 04:00 PM EDT. Market closed.

Add to Portfolio

cognition therapeutics inc. is a drug discovery and development company located in pittsburgh, pennsylvania. founded in 2007, the company uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
29
URL
Address
.
PRICE CHART FOR COGNITION THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.97
Previous Close
$1.98
Days Range
$1.90 - $1.98
52 week range
$0.90 - $3.49
Volume
139,068
Avg. Volume (30 days)
96,546
Market Cap
$79.32M
Dividend Yield
-
P/E
-
Shares Outstanding
40,058,498
Open
$1.97
Previous Close
$1.98
Days Range
$1.90 - $1.98
52 week range
$0.90 - $3.49
Volume
139,068
Avg. Volume (30 days)
96,546
Market Cap
$79.32M
Dividend Yield
-
P/E
-
Shares Outstanding
40,058,498
FINANCIAL STATEMENTS FOR COGNITION THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR COGNITION THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Doyle John BrendanChief Financial OfficerMay 01, 2024 Option Exercise$1.958,69916,963121,125May 03, 2024, 04:07 PM
Ricciardi LisaCEO & PresidentMar 14, 2024 Buy$1.755,7009,975291,345Mar 14, 2024, 04:34 PM
Caggiano AnthonyChief Medical OfficerFeb 03, 2024 Option Exercise$2.2912,77729,25981,629Feb 09, 2024, 07:12 PM
Ricciardi LisaCEO & PresidentFeb 03, 2024 Option Exercise$2.2927,82863,726210,645Feb 09, 2024, 07:11 PM
Kreis Leslie W.DirectorNov 08, 2023 Option Exercise$1.05500,095525,100500,095Nov 13, 2023, 09:48 AM
Fletcher Aaron G.L.DirectorNov 08, 2023 Option Exercise$1.05500,095525,100500,095Nov 13, 2023, 09:47 AM
RICHSTONE ELLEN BDirectorNov 29, 2022 Buy$2.6510,00026,55010,000Nov 29, 2022, 04:57 PM
Fletcher Aaron G.L.DirectorNov 28, 2022 Buy$2.651,8714,958309,748Nov 29, 2022, 07:02 AM
Fletcher Aaron G.L.DirectorNov 28, 2022 Buy$2.6512,22032,3792,021,906Nov 29, 2022, 07:02 AM
Fletcher Aaron G.L.DirectorNov 28, 2022 Buy$2.651,9735,228326,733Nov 29, 2022, 07:02 AM
Kreis Leslie W.DirectorNov 28, 2022 Buy$2.6512,22032,3792,021,906Nov 29, 2022, 07:00 AM
Kreis Leslie W.DirectorNov 28, 2022 Buy$2.651,9735,228326,733Nov 29, 2022, 07:00 AM
Kreis Leslie W.DirectorNov 28, 2022 Buy$2.651,8714,958309,748Nov 29, 2022, 07:00 AM
Fletcher Aaron G.L.DirectorNov 16, 2022 Buy$1.4054,00975,6132,009,686Nov 17, 2022, 07:00 AM
Fletcher Aaron G.L.DirectorNov 16, 2022 Buy$1.408,72212,211324,760Nov 17, 2022, 07:00 AM
Fletcher Aaron G.L.DirectorNov 16, 2022 Buy$1.408,26911,577307,877Nov 17, 2022, 07:00 AM
Kreis Leslie W.DirectorNov 16, 2022 Buy$1.408,26911,577307,877Nov 17, 2022, 07:00 AM
Kreis Leslie W.DirectorNov 16, 2022 Buy$1.4054,00975,6132,009,686Nov 17, 2022, 07:00 AM
Kreis Leslie W.DirectorNov 16, 2022 Buy$1.408,72212,211324,760Nov 17, 2022, 07:00 AM
Ricciardi LisaCEO & PresidentNov 15, 2022 Buy$1.3012,00015,60024,500Nov 16, 2022, 08:31 AM
Wallace PeggyDirectorNov 15, 2022 Buy$1.2012,50015,00037,961Nov 16, 2022, 08:30 AM
Fletcher Aaron G.L.DirectorNov 15, 2022 Buy$1.20174,700209,640299,608Nov 16, 2022, 07:00 AM
Fletcher Aaron G.L.DirectorNov 15, 2022 Buy$1.201,141,0301,369,2361,955,677Nov 16, 2022, 07:00 AM
Fletcher Aaron G.L.DirectorNov 15, 2022 Buy$1.20184,270221,124316,038Nov 16, 2022, 07:00 AM
Kreis Leslie W.DirectorNov 15, 2022 Buy$1.20174,700209,640299,608Nov 16, 2022, 06:59 AM
Kreis Leslie W.DirectorNov 15, 2022 Buy$1.201,141,0301,369,2361,955,677Nov 16, 2022, 06:59 AM
Kreis Leslie W.DirectorNov 15, 2022 Buy$1.20184,270221,124316,038Nov 16, 2022, 06:59 AM
Wallace PeggyDirectorOct 13, 2021 Buy$12.003,00036,0003,000Oct 25, 2021, 08:18 PM
BIOS Memory SPV I, LP10% OwnerOct 13, 2021 Buy$12.0023,341280,09257,579Oct 15, 2021, 09:54 PM
BIOS Memory SPV I, LP10% OwnerOct 13, 2021 Buy$12.00144,5301,734,360899,905Oct 15, 2021, 09:54 PM
BIOS Memory SPV I, LP10% OwnerOct 13, 2021 Buy$12.0022,129265,54888,012Oct 15, 2021, 09:54 PM
BIOS Memory SPV I, LP10% OwnerOct 13, 2021 Sale$12.00901,080385,248Oct 15, 2021, 09:54 PM
BIOS Memory SPV I, LP10% OwnerOct 13, 2021 Option Exercise$0.0333,4951,072385,339Oct 15, 2021, 09:54 PM
Fletcher Aaron G.L.DirectorOct 13, 2021 Buy$12.00144,5301,734,360899,905Oct 15, 2021, 09:51 PM
Fletcher Aaron G.L.DirectorOct 13, 2021 Buy$12.0022,129265,54888,012Oct 15, 2021, 09:51 PM
Fletcher Aaron G.L.DirectorOct 13, 2021 Buy$12.0023,341280,09257,579Oct 15, 2021, 09:51 PM
Fletcher Aaron G.L.DirectorOct 13, 2021 Sale$12.00901,080385,248Oct 15, 2021, 09:51 PM
Fletcher Aaron G.L.DirectorOct 13, 2021 Option Exercise$0.0333,4951,072385,339Oct 15, 2021, 09:51 PM
Golden Seeds Cognition Therapeutics LLC10% OwnerOct 13, 2021 Sale$12.00333962,177,985Oct 15, 2021, 09:51 PM
Golden Seeds Cognition Therapeutics LLC10% OwnerOct 13, 2021 Option Exercise$0.0312,2763932,178,019Oct 15, 2021, 09:51 PM
Ogden CAP Associates, LLC10% OwnerOct 13, 2021 Sale$12.00748882,210,377Oct 15, 2021, 09:51 PM
Ogden CAP Associates, LLC10% OwnerOct 13, 2021 Option Exercise$0.0327,4718792,210,452Oct 15, 2021, 09:51 PM
Breedlove Mark H.DirectorOct 13, 2021 Option Exercise$0.034,354139404,451Oct 15, 2021, 09:02 PM
Breedlove Mark H.DirectorOct 13, 2021 Sale$12.0012144404,439Oct 15, 2021, 09:02 PM
Ricciardi LisaCEO & PresidentOct 13, 2021 Buy$12.0012,500150,00012,500Oct 14, 2021, 09:46 PM
O'Brien James MichaelChief Financial OfficerOct 13, 2021 Buy$12.005,00060,0005,000Oct 14, 2021, 09:46 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Doyle John BrendanChief Financial Officer05/01/202416,963
Ricciardi LisaCEO & President03/14/20249,975
Caggiano AnthonyChief Medical Officer02/03/202429,259
Ricciardi LisaCEO & President02/03/202463,726
Kreis Leslie W.Director11/08/2023525,100
Fletcher Aaron G.L.Director11/08/2023525,100
RICHSTONE ELLEN BDirector11/29/202226,550
Fletcher Aaron G.L.Director11/28/20224,958
Fletcher Aaron G.L.Director11/28/202232,379
Fletcher Aaron G.L.Director11/28/20225,228
Kreis Leslie W.Director11/28/202232,379
Kreis Leslie W.Director11/28/20225,228
Kreis Leslie W.Director11/28/20224,958
Fletcher Aaron G.L.Director11/16/202275,613
Fletcher Aaron G.L.Director11/16/202212,211
Fletcher Aaron G.L.Director11/16/202211,577
Kreis Leslie W.Director11/16/202211,577
Kreis Leslie W.Director11/16/202275,613
Kreis Leslie W.Director11/16/202212,211
Ricciardi LisaCEO & President11/15/202215,600
Wallace PeggyDirector11/15/202215,000
Fletcher Aaron G.L.Director11/15/2022209,640
Fletcher Aaron G.L.Director11/15/20221,369,236
Fletcher Aaron G.L.Director11/15/2022221,124
Kreis Leslie W.Director11/15/2022209,640
Kreis Leslie W.Director11/15/20221,369,236
Kreis Leslie W.Director11/15/2022221,124
Wallace PeggyDirector10/13/202136,000
BIOS Memory SPV I, LP10% Owner10/13/2021280,092
BIOS Memory SPV I, LP10% Owner10/13/20211,734,360
BIOS Memory SPV I, LP10% Owner10/13/2021265,548
BIOS Memory SPV I, LP10% Owner10/13/20211,080
BIOS Memory SPV I, LP10% Owner10/13/20211,072
Fletcher Aaron G.L.Director10/13/20211,734,360
Fletcher Aaron G.L.Director10/13/2021265,548
Fletcher Aaron G.L.Director10/13/2021280,092
Fletcher Aaron G.L.Director10/13/20211,080
Fletcher Aaron G.L.Director10/13/20211,072
Golden Seeds Cognition Therapeutics LLC10% Owner10/13/2021396
Golden Seeds Cognition Therapeutics LLC10% Owner10/13/2021393
Ogden CAP Associates, LLC10% Owner10/13/2021888
Ogden CAP Associates, LLC10% Owner10/13/2021879
Breedlove Mark H.Director10/13/2021139
Breedlove Mark H.Director10/13/2021144
Ricciardi LisaCEO & President10/13/2021150,000
O'Brien James MichaelChief Financial Officer10/13/202160,000
Load More Insider Transactions
FUNDS WITH A POSITION IN COGNITION THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC185,1960.00003%5.95%Other
RENAISSANCE TECHNOLOGIES LLC155,7000.00044%1197.5%Other
BLACKROCK INC.55,8200%0.38%Other
CHANGE IN SHARES OUTSTANDING FOR COGNITION THERAPEUTICS INC
STOCK BUYBACKS FOR COGNITION THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
8.73%
1Q
03/31/2024
09/30/2023
11.10%
2Q
03/31/2024
06/30/2023
13.91%
3Q
03/31/2024
03/31/2023
15.95%
4Q
03/31/2024
12/31/2022
27.27%
5Q
03/31/2024
09/30/2022
46.52%
6Q
03/31/2024
06/30/2022
49.30%
7Q
03/31/2024
03/31/2022
50.42%
8Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
8.73%
1Q
09/30/2023
11.10%
2Q
06/30/2023
13.91%
3Q
03/31/2023
15.95%
4Q
12/31/2022
27.27%
5Q
09/30/2022
46.52%
6Q
06/30/2022
49.30%
7Q
03/31/2022
50.42%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR COGNITION THERAPEUTICS INC
LOADING...